Hester Biosciences Ltd.
| BSE: 524669 | Sector: Health care |
| NSE: HESTERBIO | ISIN Code: INE782E01017 |
| BSE 16:00 | 13 Apr | 2019.60 |
29.95 (1.51%) |
OPEN
2025.05 |
HIGH
2073.45 |
LOW
1982.00 |
| NSE 15:58 | 13 Apr | 2016.75 |
25.15 (1.26%) |
OPEN
2007.55 |
HIGH
2075.00 |
LOW
1979.85 |
| OPEN | 2025.05 |
| PREVIOUS CLOSE | 1989.65 |
| VOLUME | 2144 |
| 52-Week high | 2279.80 |
| 52-Week low | 960.00 |
| P/E | 47.67 |
| Mkt Cap.(Rs cr) | 1,719 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Hester Biosciences Ltd. (HESTERBIO) - Net Sales
Market Cap
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Sales (Rs crore) |
| Aurobindo Pharma | 909.75 | -6.40 | -0.70 | 13266.48 |
| Cipla | 885.20 | -17.80 | -1.97 | 12659.15 |
| Sun Pharma.Inds. | 627.40 | 8.25 | 1.33 | 12531.93 |
| Dr Reddy's Labs | 4780.60 | -208.60 | -4.18 | 11850.40 |
| Lupin | 1037.15 | -8.60 | -0.82 | 11025.66 |
| Apollo Hospitals | 2978.40 | -33.50 | -1.11 | 9794.50 |
| Glenmark Pharma. | 511.95 | 13.60 | 2.73 | 6712.63 |
| Alkem Lab | 2754.60 | 9.90 | 0.36 | 6677.08 |
| Cadila Health. | 488.55 | -11.40 | -2.28 | 6347.40 |
| Torrent Pharma. | 2580.30 | 24.65 | 0.96 | 6168.44 |
| Divi's Lab. | 3720.25 | -63.15 | -1.67 | 5310.57 |
| Ipca Labs. | 2154.05 | 0.30 | 0.01 | 4337.82 |
| Piramal Enterp. | 1718.45 | 89.25 | 5.48 | 4219.19 |
| Alembic Pharma | 974.65 | 16.85 | 1.76 | 4132.55 |
| Abbott India | 14974.95 | -83.85 | -0.56 | 4093.14 |
| Glaxosmi. Pharma | 1459.20 | 4.90 | 0.34 | 3224.68 |
| Jubilant Pharmo | 743.90 | 14.30 | 1.96 | 3139.90 |
| Sanofi India | 8045.00 | -52.85 | -0.65 | 2901.10 |
| Laurus Labs | 439.65 | 23.45 | 5.63 | 2797.34 |
| Gland Pharma | 2537.90 | -57.80 | -2.23 | 2633.24 |
Quick Links for Hester Biosciences:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
